glutamic acid has been researched along with ucb 35625 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
da Fonseca, PC; de Mendonça, FL; Pease, JE; Phillips, RM; Saldanha, JW; Williams, TJ | 1 |
Allen, RA; da Fonseca, PC; Duchesnes, C; Pease, JE; Williams, TJ; Wise, EL | 1 |
2 other study(ies) available for glutamic acid and ucb 35625
Article | Year |
---|---|
Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
Topics: Amino Acid Sequence; Binding Sites; Binding, Competitive; Cell Membrane; Cell Movement; Chemotaxis; Dose-Response Relationship, Drug; Glutamic Acid; Humans; Inflammation; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Point Mutation; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, CCR1; Receptors, Chemokine; Sequence Homology, Amino Acid; Signal Transduction; Software; Stereoisomerism; Transfection; Xanthenes | 2005 |
Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
Topics: Animals; Binding Sites; Cell Line, Tumor; Chemokine CCL11; Chemokines; Chemokines, CC; Down-Regulation; Eosinophils; Glutamic Acid; Mice; Models, Biological; Molecular Conformation; Receptors, CCR3; Receptors, Chemokine; Tyrosine; Up-Regulation; Xanthenes | 2007 |